Ski, I’m expecting extension to be given as its a given they’ll get it. I then expect to see Ceplene sold to Vector in June or July. I’m hoping to see a sale motion for assets after extension is given. Since it could take 20 days for motion to be approved, I suspect July would be the month. August will be plan of reorganization. Then they need acceptance which takes awhile. Now there could be one other plan and that’s a merger hence why all the delays. That’s a very big possibility. So is some sidebar. So really only two choices. I choose the first one as I prefer a liquidation and not carry on as a going concern. But, if the split was graceful and kind, then maybe merger would be fine. The last merger was a 45 split. But the share price had also been much higher. So I doubt a merger unless they figure releasing UC results may help them lift price before they had to announce merger. The fact that they haven’t released UC results is a little telling. Maybe bidders get preferential treatment with results for UC. We will easily see that in bids. Just ignore any first low bid. If you see anyone familiar like Vector, just assume it’s game over and merger is the plan. Fun times. It will be a long summer. Once I saw that request to extend, I knew this was going to be delayed. No surprises here. Zero!!!
